A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SAL0167 in Healthy Participants
Clinical trial NCT07722299 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07722299
- Sponsor
- Shenzhen Salubris Pharmaceuticals Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-21
- Primary completion
- 2027-07-31
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.